COMMUNIQUÉS West-GlobeNewswire

scPharmaceuticals Announces Appointment of Two New Directors
24/07/2018
BURLINGTON, Mass., July 24, 2018 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq:SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of [...]
Inovio Pharmaceuticals to Report Second Quarter 2018 Financial Results on August 7, 2018
24/07/2018
PLYMOUTH MEETING, Pa., July 24, 2018 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) announced today that it will host a conference call and live webcast to report its 2018 second quarter financial results [...]
Cue Biopharma Appoints Bethany Mancilla as Chief Business Officer and Senior Vice President
24/07/2018
Mancilla Brings Broad Immunotherapy Business Development and Biopharmaceutical Industry Experience CAMBRIDGE, Mass., July 24, 2018 (GLOBE NEWSWIRE) -- Cue Biopharma , Inc., (NASDAQ:CUE) a next-generation immunotherapy [...]
7 Hills Pharma Appoints Lionel D. Lewis as Chief Medical Officer
24/07/2018
HOUSTON, July 24, 2018 (GLOBE NEWSWIRE) -- 7 Hills Pharma, a privately-held immunotherapy company focused on development of novel tumor-targeting cell adhesion agents, today announced the appointment of Lionel D. Lewis [...]
Biotricity Completes Alpha Version of Deep Data Diagnostic Solution
24/07/2018
Biotricity is Testing its Deep Data and AI Technology, to be implemented in planned Bioflux 2.0, for Improved Patient Outcomes and Call Center Efficiency while Reducing Costs and Diagnostic Time REDWOOD CITY, Calif., [...]
HTG Molecular Diagnostics to Announce Second Quarter and Six Months Ended June 30, 2018 Financial Results and Host Conference Call on Tuesday, August 7
24/07/2018
TUCSON, Ariz., July 24, 2018 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM), a provider of instruments, reagents, and services for molecular profiling applications, today announced that it will report [...]
Emerald Health Therapeutics Signs Cannabis Supply Memorandum of Understanding with British Columbia Liquor Distribution Branch
24/07/2018
VICTORIA, British Columbia, July 24, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (TSXV:EMH) (OTCQX:EMHTF) (“Emerald”) has signed a Memorandum of Understanding ("MOU") with the British Columbia Liquor [...]
Loop Industries helps make Gatorade Gx packaging more sustainable
24/07/2018
Loop Industries help Gatorade Gx consumers recover and upcycle plastic TERREBONNE, Quebec, July 24, 2018 (GLOBE NEWSWIRE) -- Loop Industries, Inc. (Nasdaq:LOOP) today announced a free new program that allows consumers [...]
Geron to Announce Second Quarter 2018 Financial Results on July 31, 2018
24/07/2018
MENLO PARK, Calif., July 24, 2018 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced that it will release its second quarter 2018 financial results after the market closes on Tuesday, July 31, 2018. The [...]
NanoVibronix Reports Successful Trial Results for Use of PainShield™ in Patients with Trigeminal Neuralgia; Reinforces Potential as Alternative to Opioids and Surgical Interventions
24/07/2018
ELMSFORD, N.Y., July 24, 2018 (GLOBE NEWSWIRE) -- NanoVibronix, Inc, (NASDAQ:NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today [...]
GSK and Adaptimmune Complete Transition of NY-ESO SPEAR T-cell Therapy Program to GSK
24/07/2018
LONDON and OXFORD, United Kingdom, July 24, 2018 (GLOBE NEWSWIRE) -- GlaxoSmithKline plc and Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, today announced the transition of the [...]
Freedom Laser Therapy Expands iRestore Reseller Program For Hair Care Professionals
24/07/2018
Company Introduces New Affiliate Card Program for the iRestore Laser Hair Growth System LOS ANGELES, July 24, 2018 (GLOBE NEWSWIRE) -- Freedom Laser Therapy , creator of the FDA cleared and clinically proven iRestore [...]
Aptose To Release Second Quarter Ended June 30, 2018 Financial Results and Hold Conference Call on August 7, 2018
24/07/2018
SAN DIEGO and TORONTO, July 24, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ:APTO) (TSX:APS), a clinical-stage company developing highly differentiated therapeutics targeting the underlying mechanisms of [...]
Immuron Announces it has Received a European Patent Grant for NASH treatment
24/07/2018
MELBOURNE, Australia, July 24, 2018 (GLOBE NEWSWIRE) -- Immuron Limited (ASX:IMC) (NASDAQ:IMRN) is an Australian microbiome biopharmaceutical Company focused on developing and commercializing orally delivered targeted [...]
US Department of Defense Research Collaboration Moves Forward
24/07/2018
Key Highlights: Three US Defense Health funded research projects on Travelan® successfully completed Studies commissioned by the US Department of Defense to evaluate Travelan®’s ability to neutralise pathogenic bacteria [...]
Industry Accolades for Saccade Analytics Groundbreaking Neurological Evaluation Tool
24/07/2018
Awards Recognizing Innovation and Rapid Growth Keep Accruing for the Canadian Medical Software Start-Up Saccade Analytics MONTREAL, July 24, 2018 (GLOBE NEWSWIRE) -- Saccade Analytics is pleased to announce that it has [...]
EDAP TMS SA : EDAP TMS SA to Announce Second Quarter 2018 Financial Results on Thursday, August 30
24/07/2018
LYON, France, July 24, 2018 - EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, today announced that it will release its financial results for the second quarter and six months ended June 30, 2018 [...]
Dr. Thomas A. Finley, M.D. Appointed as Chairmen of Ocutrx International Medical Advisory Board
24/07/2018
Oculenz™ AR Glasses Garners Important Medical Support for Restoring Functional Sight to Patients with Visual Field Deficits IRVINE, Calif., July 24, 2018 (GLOBE NEWSWIRE) -- Ocutrx Vision Technologies, LLC, a California [...]
Amarin to Report Second Quarter 2018 Results and Host Conference Call on August 1, 2018
24/07/2018
BEDMINSTER, N.J. and DUBLIN, Ireland, July 24, 2018 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve [...]

Pages